Old Web
English
Sign In
Acemap
>
authorDetail
>
Helen M. Armstrong
Helen M. Armstrong
Merck & Co.
Biochemistry
Chemistry
Organic chemistry
5-lipoxygenase-activating protein
5-Lipoxygenase-Activating Protein Inhibitors
3
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors.
2012
Bioorganic & Medicinal Chemistry Letters
Lin Chu
Helen M. Armstrong
Linda L. Chang
Amy F. Cheng
Lawrence F. Colwell
Jisong Cui
Jilly F. Evans
Amy Galka
Mark T. Goulet
Nancy S. Hayes
Jane Lo
John G. Menke
Hyun O. Ok
Debra Ondeyka
Minal Patel
Grace Quaker
Heather L. Sings
Stephanie L. Witkin
Annie Zhao
Feroze Ujjainwalla
Show All
Source
Cite
Save
Citations (15)
F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist
2006
European Journal of Pharmacology
Chun-Pyn Shen
Jing Chen Xiao
Helen M. Armstrong
William K. Hagmann
Tung M. Fong
Show All
Source
Cite
Save
Citations (20)
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity.
1999
Bioorganic & Medicinal Chemistry Letters
Helen M. Armstrong
Frederick Wong
Mark A. Holmes
Peter J. Sinclair
Mark T. Goulet
Francis J. Dumont
Mary Jo Staruch
Samuel Koprak
Laurence B. Peterson
Raymond Rosa
Mary Beth Wilusz
Gregory J. Wiederrecht
John G. Cryan
Matthew J. Wyvratt
William H. Parsons
Show All
Source
Cite
Save
Citations (4)
1